Cargando…

COVID-19 Vaccines and Myocarditis: An Overview of Current Evidence

COVID-19 vaccines have been widely used to reduce the incidence and disease severity of COVID-19. Questions have lately been raised about the possibility of an association between COVID-19 vaccines and myocarditis, an inflammatory condition affecting the myocardium, or the middle layer of the heart....

Descripción completa

Detalles Bibliográficos
Autores principales:	Hromić-Jahjefendić, Altijana, Sezer, Abas, Aljabali, Alaa A. A., Serrano-Aroca, Ángel, Tambuwala, Murtaza M., Uversky, Vladimir N., Redwan, Elrashdy M., Barh, Debmalya, Lundstrom, Kenneth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216497/ https://www.ncbi.nlm.nih.gov/pubmed/37239140 http://dx.doi.org/10.3390/biomedicines11051469

Ejemplares similares

Can COVID-19 Vaccines Induce Premature Non-Communicable Diseases: Where Are We Heading to?
por: Hromić-Jahjefendić, Altijana, et al.
Publicado: (2023)

Associations and Disease–Disease Interactions of COVID-19 with Congenital and Genetic Disorders: A Comprehensive Review
por: Hromić-Jahjefendić, Altijana, et al.
Publicado: (2022)

COVID-19 signalome: Pathways for SARS-CoV-2 infection and impact on COVID-19 associated comorbidity
por: Lundstrom, Kenneth, et al.
Publicado: (2023)

Would New SARS-CoV-2 Variants Change the War against COVID-19?
por: Redwan, Elrashdy M., et al.
Publicado: (2022)

COVID-19 signalome: Potential therapeutic interventions
por: Lundstrom, Kenneth, et al.
Publicado: (2023)

Viral Vector-Based Melanoma Gene Therapy
por: Hromic-Jahjefendic, Altijana, et al.
Publicado: (2020)

Viral Agents as Potential Drivers of Diffuse Large B-Cell Lymphoma Tumorigenesis
por: Bilajac, Esma, et al.
Publicado: (2022)

Biomedical applications of three‐dimensional bioprinted craniofacial tissue engineering
por: Charbe, Nitin Bharat, et al.
Publicado: (2022)

Nanomaterials and Their Impact on the Immune System
por: Aljabali, Alaa A., et al.
Publicado: (2023)

Predicting COVID-19—Comorbidity Pathway Crosstalk-Based Targets and Drugs: Towards Personalized COVID-19 Management
por: Barh, Debmalya, et al.
Publicado: (2021)

Potential Molecular Mechanisms of Rare Anti-Tumor Immune Response by SARS-CoV-2 in Isolated Cases of Lymphomas
por: Barh, Debmalya, et al.
Publicado: (2021)

Emergence of unique SARS-CoV-2 ORF10 variants and their impact on protein structure and function
por: Hassan, Sk. Sarif, et al.
Publicado: (2022)

Curcumin Decreases Viability and Inhibits Proliferation of Imatinib-Sensitive and Imatinib-Resistant Chronic Myeloid Leukemia Cell Lines
por: Bilajac, Esma, et al.
Publicado: (2022)

Periodically aperiodic pattern of SARS-CoV-2 mutations underpins the uncertainty of its origin and evolution
por: Hassan, Sk Sarif, et al.
Publicado: (2022)

Non-uniform aspects of the SARS-CoV-2 intraspecies evolution reopen question of its origin
por: Hassan, Sk. Sarif, et al.
Publicado: (2022)

Autoimmunity roots of the thrombotic events after COVID-19 vaccination
por: Elrashdy, Fatma, et al.
Publicado: (2021)

Meet the Insidious Players: Review of Viral Infections in Head and Neck Cancer Etiology with an Update on Clinical Trials
por: Mahmutović, Lejla, et al.
Publicado: (2021)

SARS-CoV-2 Variants Show a Gradual Declining Pathogenicity and Pro-Inflammatory Cytokine Stimulation, an Increasing Antigenic and Anti-Inflammatory Cytokine Induction, and Rising Structural Protein Instability: A Minimal Number Genome-Based Approach
por: Barh, Debmalya, et al.
Publicado: (2022)

Alginate: Enhancement Strategies for Advanced Applications
por: Hurtado, Alejandro, et al.
Publicado: (2022)

Implications derived from S-protein variants of SARS-CoV-2 from six continents
por: Hassan, Sk. Sarif, et al.
Publicado: (2021)

An issue of concern: unique truncated ORF8 protein variants of SARS-CoV-2
por: Hassan, Sk. Sarif, et al.
Publicado: (2022)

Clinical utility of novel biosensing platform: Diagnosis of coronavirus SARS-CoV-2 at point of care
por: Aljabali, Alaa A.A., et al.
Publicado: (2021)

COVID-19 Vaccines and Thrombosis—Roadblock or Dead-End Street?
por: Lundstrom, Kenneth, et al.
Publicado: (2021)

Ran GTPase and Its Importance in Cellular Signaling and Malignant Phenotype
por: El-Tanani, Mohamed, et al.
Publicado: (2023)

The importance of accessory protein variants in the pathogenicity of SARS-CoV-2
por: Hassan, Sk. Sarif, et al.
Publicado: (2022)

The mechanism behind flaring/triggering of autoimmunity disorders associated with COVID-19
por: Redwan, Elrashdy M., et al.
Publicado: (2021)

COVID-19 pandemic: an overview of epidemiology, parthenogenesis, diagnostics and potential vaccines and therapeutics
por: Amawi, Haneen, et al.
Publicado: (2020)

Intrinsic disorder perspective of an interplay between the renin-angiotensin-aldosterone system and SARS-CoV-2
por: Elrashdy, Fatma, et al.
Publicado: (2020)

Why COVID-19 Transmission Is More Efficient and Aggressive Than Viral Transmission in Previous Coronavirus Epidemics?
por: Elrashdy, Fatma, et al.
Publicado: (2020)

Notable sequence homology of the ORF10 protein introspects the architecture of SARS-CoV-2
por: Hassan, Sk. Sarif, et al.
Publicado: (2021)

Scaffolds in the microbial resistant era: Fabrication, materials, properties and tissue engineering applications
por: Serrano-Aroca, Ángel, et al.
Publicado: (2022)

A unique view of SARS-CoV-2 through the lens of ORF8 protein
por: Hassan, Sk Sarif, et al.
Publicado: (2021)

Co-infection associated with SARS-CoV-2 and their management
por: Chavda, Vivek P, et al.
Publicado: (2023)

Latent potentials of camel’s milk
por: Redwan, Elrashdy M., et al.
Publicado: (2022)

Frontiers in Antimicrobial Materials
por: Serrano-Aroca, Ángel, et al.
Publicado: (2022)

Simple and efficient protocol for immunoglobulin Y purification from chicken egg yolk
por: Redwan, Elrashdy M., et al.
Publicado: (2020)

Protein Intrinsic Disorder and Evolvability of MERS-CoV
por: Uversky, Vladimir N., et al.
Publicado: (2021)

Hepatitis C Virus Infection and Intrinsic Disorder in the Signaling Pathways Induced by Toll-Like Receptors
por: Redwan, Elrashdy M., et al.
Publicado: (2022)

Natural resources to control COVID-19: could lactoferrin amend SARS-CoV-2 infectivity?
por: Mattar, Ehab H., et al.
Publicado: (2021)

Structural disorder in the proteome and interactome of Alkhurma virus (ALKV)
por: Redwan, Elrashdy M., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_be9k7qtqsmvpu7t79q79k557g3